Outcomes and Challenges in the Programmatic Implementation of Tuberculosis Preventive Therapy among Household Contacts of Pulmonary TB Patients: A Mixed-Methods Study from a Rural District of Karnataka, India.
U C SamudyathaSoundappan KathirvelGomathi RamaswamyKedar MehtaChandan KumarM JagadeeshB T Prasanna KamathNeeta SinglaPruthu ThekkurPublished in: Tropical medicine and infectious disease (2023)
The National TB Elimination Programme (NTEP) of India is implementing tuberculosis preventive treatment (TPT) for all household contacts (HHCs) of pulmonary tuberculosis patients (index patients) aged <5 years and those HHCs aged >5 years with TB infection (TBI). We conducted an explanatory mixed-methods study among index patients registered in the Kolar district, Karnataka during April-December 2022, to assess the TPT cascade and explore the early implementation challenges for TPT provision. Of the 301 index patients, contact tracing home visits were made in 247 (82.1%) instances; a major challenge was index patients' resistance to home visits fearing stigma, especially among those receiving care from the private sector. Of the 838 HHCs, 765 (91.3%) were screened for TB; the challenges included a lack of clarity on HHC definition and the non-availability of HHCs during house visits. Only 400 (57.8%) of the 692 eligible HHCs underwent an IGRA test for TBI; the challenges included a shortage of IGRA testing logistics and the perceived low risk among HHCs. As HHCs were unaware of their IGRA results, a number of HHCs actually eligible for TPT could not be determined. Among the 83 HHCs advised of the TPT, 81 (98%) initiated treatment, of whom 63 (77%) completed treatment. Though TPT initiation and completion rates are appreciable, the NTEP needs to urgently address the challenges in contact identification and IGRA testing.
Keyphrases
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- healthcare
- mycobacterium tuberculosis
- prognostic factors
- traumatic brain injury
- stem cells
- randomized controlled trial
- bone marrow
- mental health
- quality improvement
- patient reported outcomes
- south africa
- adipose tissue
- pulmonary hypertension
- weight loss
- mental illness
- human immunodeficiency virus
- drug induced
- cell therapy